81 Views | 37 Downloads
J. Lucas McKay, lucas@dbmi.emory.edu
Conceptualization, H.K., S.F., and L.M.; methodology, H.K.; software, H.K.; validation, H.K., I.G., and L.M.; formal analysis, H.K. and L.M.; investigation, H.K. and L.M.; resources, S.F., L.M., G.D., and C.E.; data curation, D.B. and L.M.; writing—original draft preparation, H.K.; writing—review and editing, L.M., G.D., I.G., C.E., S.F.; visualization, H.K.; supervision, G.D., L.M., and S.F.; project administration, L.M. and S.F.; funding acquisition, S.F. and L.M. All authors have read and agreed to the published version of the manuscript.
The computational needs for this research are supported in part by Oracle Cloud credits and related resources provided by the Oracle for Research program.
J.L.M. performs paid consulting work for Biocircuit technologies. None of these interests are directly related to the outcomes of this study. S.A.F. has the following competing interests: Honoraria: Lundbeck, Teva, Sunovion, Biogen, Acadia, Neuroderm, Acorda, CereSpire. Grants: Ipsen, Medtronics, Boston Scientific, Teva, US World Meds, Sunovion Therapeutics, Vaccinex, Voyager, Jazz Pharmaceuticals, Lilly, CHDI Foundation, Michael J. Fox Foundation, NIH, Royalties: Demos, Blackwell Futura for textbooks, Uptodate, Other Bracket Global LLC, CNS Ratings LLC. None of these interests are directly related to the outcomes of this study. The other authors declare no other interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
This research was funded by The McCamish Center for Parkinson’s Disease Innovation, the by Curtis Family Fund, Sartain Lanier Family Foundation (S.A.F.), and NIH K25HD086276 (J.L.M.).